Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $31,019 | 1,819 | 93.9% |
| Gift | $1,575 | 1 | 4.8% |
| Education | $433.41 | 31 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $6,003 | 277 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,718 | 252 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,816 | 156 | $0 (2024) |
| Novo Nordisk Inc | $2,371 | 181 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,802 | 90 | $0 (2024) |
| Amgen Inc. | $1,783 | 111 | $0 (2024) |
| PFIZER INC. | $1,764 | 137 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,592 | 122 | $0 (2024) |
| Welch Allyn | $1,575 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $1,067 | 58 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,508 | 134 | AstraZeneca Pharmaceuticals LP ($1,413) |
| 2023 | $3,624 | 155 | AstraZeneca Pharmaceuticals LP ($680.81) |
| 2022 | $3,685 | 200 | Boehringer Ingelheim Pharmaceuticals, Inc. ($442.13) |
| 2021 | $4,284 | 259 | AstraZeneca Pharmaceuticals LP ($661.93) |
| 2020 | $3,892 | 265 | AstraZeneca Pharmaceuticals LP ($749.94) |
| 2019 | $5,011 | 329 | AstraZeneca Pharmaceuticals LP ($758.24) |
| 2018 | $5,590 | 269 | Welch Allyn ($1,575) |
| 2017 | $3,432 | 240 | AstraZeneca Pharmaceuticals LP ($559.11) |
All Payment Transactions
1,851 individual payment records from CMS Open Payments — Page 1 of 75
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: PAIN | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.26 | General |
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: PAIN | ||||||
| 12/06/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Analgesic | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,271 | 5,508 | $890,834 | $424,478 |
| 2022 | 23 | 2,385 | 6,129 | $881,985 | $455,112 |
| 2021 | 21 | 2,135 | 5,807 | $800,330 | $428,571 |
| 2020 | 24 | 2,499 | 6,224 | $783,485 | $365,289 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 521 | 1,467 | $284,480 | $152,689 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 526 | 1,612 | $221,670 | $120,990 | 54.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 128 | 644 | $112,700 | $58,935 | 52.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 134 | 447 | $64,815 | $28,942 | 44.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 115 | 143 | $35,750 | $15,444 | 43.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 169 | 220 | $18,755 | $10,505 | 56.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 30 | $17,400 | $8,025 | 46.1% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 64 | 68 | $9,180 | $4,626 | 50.4% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 28 | 28 | $38,135 | $3,756 | 9.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,145 | $3,556 | 38.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 31 | 33 | $30,452 | $3,129 | 10.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 46 | 60 | $7,500 | $3,045 | 40.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 95 | 146 | $3,650 | $1,390 | 38.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 51 | 92 | $4,140 | $1,254 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,750 | $1,199 | 43.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 14 | 14 | $2,870 | $1,188 | 41.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 86 | 90 | $4,050 | $1,169 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,775 | $1,065 | 38.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 59 | 81 | $3,240 | $1,063 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 15 | $11,070 | $970.86 | 8.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 14 | 17 | $1,615 | $735.65 | 45.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 22 | 29 | $1,305 | $509.24 | 39.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 35 | 164 | $1,640 | $135.13 | 8.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 19 | 19 | $1,267 | $123.31 | 9.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 32 | $480.00 | $37.09 | 7.7% |
About Daniel Wang
Daniel Wang is a Family Medicine healthcare provider based in Hollister, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346336195.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Wang has received a total of $33,027 in payments from pharmaceutical and medical device companies, with $3,508 received in 2024. These payments were reported across 1,851 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($31,019).
As a Medicare-enrolled provider, Wang has provided services to 9,290 Medicare beneficiaries, totaling 23,668 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hollister, CA
- Active Since 10/05/2006
- Last Updated 11/29/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346336195
Products in Payments
- FARXIGA (Drug) $3,171
- TRELEGY ELLIPTA (Drug) $1,907
- JARDIANCE (Drug) $1,680
- SCP Cardioperfect Pro Recorder (Device) $1,575
- XARELTO (Drug) $1,442
- Ozempic (Drug) $1,137
- BREZTRI (Drug) $1,063
- Aimovig (Biological) $826.80
- JANUVIA (Drug) $787.52
- ELIQUIS (Drug) $730.66
- NURTEC ODT (Drug) $724.10
- BEVESPI AEROSPHERE (Drug) $717.52
- STIOLTO RESPIMAT (Drug) $677.58
- ENTRESTO (Drug) $640.56
- Kerendia (Drug) $618.41
- BELSOMRA (Drug) $526.61
- VRAYLAR (Drug) $512.45
- Otezla (Drug) $511.61
- CHANTIX (Drug) $508.57
- ANORO (Drug) $491.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hollister
Marie Claudette Grageda, Md, MD
Family Medicine — Payments: $14,695
Dr. Marni Friedman, M.d, M.D
Family Medicine — Payments: $13,925
Peter Coelho, M.d, M.D
Family Medicine — Payments: $8,581
Arminda Tolentino, M.d, M.D
Family Medicine — Payments: $1,358
Dr. Kevin Herrick, Md, MD
Family Medicine — Payments: $266.64
Benedict Carota, Md, MD
Family Medicine — Payments: $260.18